Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

FDC Ltd.

FDC

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹79.30 Cr.

EX-Date	Purpose
26 05 2021	Audited Results
12 08 2021	Quarterly Results
11 11 2021	Quarterly Results
09 02 2022	Quarterly Results
25 05 2022	Quarterly Results & Audited Results
04 08 2022	Quarterly Results
14 11 2022	Quarterly Results
09 02 2023	Quarterly Results
25 05 2023	Audited Results & Quarterly Results
09 08 2023	Quarterly Results & Buy Back of Shares
08 11 2023	Quarterly Results
07 02 2024	Quarterly Results
06 11 2024	Quarterly Results
06 11 2024	Interim Dividend
12 02 2025	Quarterly Results
28 05 2025	Audited Results

News

12-MAY-2025

The drugmaker initiated the Class II nationwide (US) recall on April 18, 2025

12:44 PM

13-FEB-2023

The said audit has been successfully completed by the USFDA with No observations

03:39 PM

15-JUN-2023

USFDA had conducted an inspection at said manufacturing facility from February 6, 2023 to February 12, 2023

03:52 PM

15-JUN-2023

USFDA had conducted an inspection at said manufacturing facility from March 20, 2023 to March 24, 2023

02:51 PM

18-DEC-2024

The company has received final approval from U.S. Food and Drug Administration

05:08 PM

18-NOV-2024

The company initiated the Class II recall on October 29, 2024

11:00 AM

25-NOV-2022

FAVENZA was recognized for New Introduction of the Year in Acute Therapy

10:47 AM

27-MAR-2023

The said audit has been successfully completed by the USFDA with ’No observations’

04:08 PM